What is Bicara Therapeutics's non-cash lease expense?

Bicara Therapeutics (BCAX) reported non-cash lease expense of $273K in Q1 2026.

How has Bicara Therapeutics's non-cash lease expense changed year-over-year?

Bicara Therapeutics's non-cash lease expense increased by 97.8% year-over-year, from $138K to $273K.

What does non-cash lease expense mean?

Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.

Bicara Therapeutics BCAX Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

ImmunomeIMNM

$150K+30.4%

Arcus BiosciencesRCUS

$2M0.0%

Immunovant, Inc.IMVT

$26K+18.2%

BridgeBio PharmaBBIO

$1.47M+47.5%

Natera, Inc.NTRA

$5.93M+35.1%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's non-cash lease expense?: Bicara Therapeutics (BCAX) reported non-cash lease expense of $273K in Q1 2026.
How has Bicara Therapeutics's non-cash lease expense changed year-over-year?: Bicara Therapeutics's non-cash lease expense increased by 97.8% year-over-year, from $138K to $273K.
What does non-cash lease expense mean?: Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.